Brach Eichler Talks

Update Regarding the Corporate Transparency Act

In this episode, we discuss the latest update on the Corporate Transparency Act (CTA) and what it means for businesses. The U.S. Department of the Treasury has announced changes to the enforcement of beneficial ownership reporting requirements, including a delay in penalties and a narrowed scope focusing on foreign entities. We also break down key deadlines and what companies need to know to stay compliant. Tune in for essential insights from Brach Eichler’s legal team.
Additional information can be found on FinCEN’s website.
If you have any questions about this article, please contact any of the attorneys listed below or your usual Brach Eichler contact person.
John D. Fanburg, Managing Member and Chair, Healthcare Law Practice, at jfanburg@bracheichler.com or 973-403-3107
Edward Hilzenrath, Member, Healthcare Law Practice, at ehilzenrath@bracheichler.com or 973-403-3114
David L. Tsin, Counsel, Corporate Transactions & Financial Services Practice, at dtsin@bracheichler.com or 973-364-5237
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

Operators of New Jersey Nursing Home Accused of Medicaid Fraud

New Jersey’s Office of the State Comptroller (OSC) has uncovered a shocking Medicaid fraud scheme involving South Jersey Extended Care (SJEC). In this episode, we break down the five-year investigation that revealed how SJEC operators Michael Koning and Steven Krausman, along with straw owner Mark Weisz, allegedly siphoned millions in Medicaid funds into their personal businesses—leaving the nursing home underfunded and understaffed. We also discuss the regulatory loopholes that enabled this scheme and the OSC’s recommendations to prevent future fraud in the Medicaid program. Tune in to learn more about this alarming case and its impact on the healthcare system.
Click Here to read the entire February 2024 Healthcare Law Update now!
For more information, contact:Riza I. Dagli | 973.403.3103 | rdagli@bracheichler.comEdward J. Yun | 973.364.5229 | eyun@bracheichler.comCynthia J. Liba | 973.403.3106 | cliba@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

Update Regarding the Corporate Transparency Act and Related Filing Deadlines

Stay up to date on the latest developments regarding the Corporate Transparency Act (CTA) and key filing deadlines. In this episode, we break down the impact of the recent U.S. District Court ruling that reinstates the CTA’s beneficial ownership information reporting requirements. Learn what this means for Reporting Companies, the updated March 21, 2025, deadline, and potential penalties for noncompliance. For businesses navigating these regulations, this is a must-listen update from Brach Eichler’s Corporate Transactions & Financial Services team.
For more information or legal guidance, contact John D. Fanburg at jfanburg@bracheichler.com, Edward Hilzenrath at ehilzenrath@bracheichler.com, or David L. Tsin at dtsin@bracheichler.com.
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

Job Applicants Have No Right to Sue Under New Jersey’s Adult-Use Cannabis Law

Can job applicants in New Jersey sue if they're rejected due to a positive cannabis test? A recent Third Circuit Court ruling says no. In this episode, we break down the court's decision, its implications for employers, and the lingering uncertainties surrounding cannabis testing in the workplace. What does this mean for hiring policies, legal risks, and workplace safety? Tune in as we explore these key questions and what employers need to know.
🎧 Listen now and stay informed on the latest in labor and employment law.
 
For more information about cannabis in the workplace, please contact:
Jay Sabin, Member, Labor and Employment Practice at 917-596-8987 or jsabin@bracheichler.com
 
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

Crucial Update: What You Need to Know About the Changes to the Corporate Transparency Act

Explore the latest updates to the Corporate Transparency Act and their impact on businesses. Join us as we discuss what you need to know to stay compliant. 🔗 Read the full article now: https://www.bracheichler.com/insights/crucial-update-what-you-need-to-know-about-the-changes-to-the-corporate-transparency-act/
 
For more information, contact:
- John D. Fanburg, Managing Member and Chair, Healthcare Law Practice, at jfanburg@bracheichler.com or 973-403-3107
- Edward Hilzenrath, Member, Healthcare Law Practice, at ehilzenrath@bracheichler.com or 973-403-3114
- David L. Tsin, Counsel, Corporate Transactions & Financial Services Practice, at dtsin@bracheichler.com or 973-364-5237
 
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

Enhancing Oversight of Remote Patient Monitoring in Medicare

🎙️ Our latest podcast episode dives into the evolving landscape of Remote Patient Monitoring in Medicare, covering key updates, oversight challenges, and opportunities for providers. Don't miss this essential discussion for healthcare professionals and policymakers alike! 🔗 Read the full article now: https://www.bracheichler.com/insights/enhancing-oversight-of-remote-patient-monitoring-in-medicare/
 
For more information, contact:
- John D. Fanburg, Managing Member and Chair, Healthcare at 973.403.3107 or jfanburg@bracheichler.com
- Edward J. Yun, Member, Healthcare at 973.364.5229 or eyun@bracheichler.com
- Vanessa Coleman, Associate, Healthcare at 973.364.5208 or vcoleman@bracheichler.com
 
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

Laboratory Pays $27 Million to Settle Alleged False Claims and Anti-Kickback Violations

This episode covers a lab's $27 million settlement over alleged False Claims Act and Anti-Kickback Statute violations. Discover the case details, its impact on healthcare compliance, and what it means for providers. Stay tuned for key insights!
📲 For more information, visit: https://www.bracheichler.com/insights/laboratory-pays-27-million-to-settle-alleged-false-claims-and-anti-kickback-violations/
📞 For more information, contact:- Keith J. Roberts | 973.364.5201 | kroberts@bracheichler.com- Shannon Carroll | 973.403.3126 | scarroll@bracheichler.com- Rebecca Falk | 973.364.8393 | rfalk@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.

Shore Memorial Health System Settles False Claims Act Allegations Over Improper Receipt of PPP Loan

In this episode, we cover Shore Memorial Health System's $1.7 million settlement over False Claims Act allegations for improperly receiving a PPP loan during COVID-19. We discuss the case's key details and the role of the False Claims Act in protecting government loan programs.
🔗 For more information, visit: https://www.bracheichler.com/insights/shore-memorial-health-system-settles-false-claims-act-allegations-over-improper-receipt-of-ppp-loan/
📞 For more information about the issues raised in this Alert, please contact:
- Riza I. Dagli | 973.403.3103 | rdagli@bracheichler.com
- Edward J. Yun | 973.364.5229 | eyun@bracheichler.com
- Vanessa Coleman | 973.364.5208 | vcoleman@bracheichler.com
*This is intended to provide general information, not legal advice. Please contact the authors if you need specific legal advice.